dc.contributor.author | Çelik, Oğuz Cem | |
dc.contributor.author | Kadioglu, P. | |
dc.date.accessioned | 2021-03-05T10:32:16Z | |
dc.date.available | 2021-03-05T10:32:16Z | |
dc.date.issued | 2010 | |
dc.identifier.citation | Çelik O. C. , Kadioglu P., "Medical therapy of acromegaly in Turkey", JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, cilt.33, ss.592-598, 2010 | |
dc.identifier.issn | 0391-4097 | |
dc.identifier.other | av_a39351d8-3e08-48c7-845b-f3b0cf53034c | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/109493 | |
dc.identifier.uri | https://doi.org/10.1007/bf03346654 | |
dc.description.abstract | Acromegaly is associated with multiple co-morbidities and risk of premature mortality. Mortality rate of acromegalic patients is similar to that of the general population when normal GH levels are achieved. Surgery is the mainstay of acromegaly but when surgery fails to achieve disease control, or when surgery is impossible or contraindicated, patients are offered medical therapy and/or radiotherapy. Current medical therapy modalities were revised in this short review. (J. Endocrinol. Invest. 33: 592-598, 2010) (C) 2010, Editrice Kurtis | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Endokrinoloji ve Metabolizma Hastalıkları | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ENDOKRİNOLOJİ VE METABOLİZMA | |
dc.title | Medical therapy of acromegaly in Turkey | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | |
dc.contributor.department | İstanbul Teknik Üniversitesi , Mimarlık , Mimarlık | |
dc.identifier.volume | 33 | |
dc.identifier.issue | 8 | |
dc.identifier.startpage | 592 | |
dc.identifier.endpage | 598 | |
dc.contributor.firstauthorID | 50075 | |